Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Soft Tissue Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00520936
What this trial is testing

Pemetrexed in Children With Recurrent Cancer

Who this might be right for
OsteosarcomaMedulloblastomaSarcoma, Ewing's+6 more
Eli Lilly and Company 72
Testing effectiveness (Phase 2)Ended earlyNCT02207309
What this trial is testing

Pazopanib Maintenance Phase II

Who this might be right for
Sarcoma
Ludwig-Maximilians - University of Munich 1
Not applicableLooking for participantsNCT07778212
What this trial is testing

Orelabrutinib Combined With Pola-R-CHP as First-Line Treatment for Patients With Intermediate- to High-Risk DLBCL

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaIntermediate-High RiskFirst-Line
The First Affiliated Hospital of Xiamen University 30
Testing effectiveness (Phase 2)Study completedNCT00357396
What this trial is testing

Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors

Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center 10
Early research (Phase 1)Study completedNCT00003023
What this trial is testing

Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer

Who this might be right for
NeuroblastomaSarcoma
Memorial Sloan Kettering Cancer Center 24
Testing effectiveness (Phase 2)UnknownNCT05193188
What this trial is testing

Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma

Who this might be right for
Chondrosarcoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 70
Early research (Phase 1)Study completedNCT00634504
What this trial is testing

Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze

Who this might be right for
OsteosarcomaLeukemiaLymphoma
BTG International Inc. 20
Testing effectiveness (Phase 2)Study completedNCT00003408
What this trial is testing

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Cancer Treatment Centers of America 40
Testing effectiveness (Phase 2)Study completedNCT01347034
What this trial is testing

Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS)

Who this might be right for
Soft Tissue Sarcoma
H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT06650514
What this trial is testing

Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade Osteosarcoma

Who this might be right for
OsteosarcomaOsteosarcoma in Children
Vall d'Hebron Institute of Oncology 10
Testing effectiveness (Phase 2)Looking for participantsNCT04758000
What this trial is testing

Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse

Who this might be right for
OsteosarcomaEwing Sarcoma
Istituto Ortopedico Rizzoli 67
Early research (Phase 1)WithdrawnNCT00944580
What this trial is testing

A Vaccine Study for High Risk Cancers

Who this might be right for
NeuroblastomaRhabdomyosarcomaOsteogenic Sarcoma
Penn State University
Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Early research (Phase 1)Ended earlyNCT04099277
What this trial is testing

LY3435151 in Participants With Solid Tumors

Who this might be right for
Solid TumorTriple-negative Breast CancerGastric Adenocarcinoma+6 more
Eli Lilly and Company 2
Testing effectiveness (Phase 2)Study completedNCT01459484
What this trial is testing

ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma

Who this might be right for
Osteosarcoma
Italian Sarcoma Group 225
Testing effectiveness (Phase 2)Study completedNCT02727387
What this trial is testing

Protocol for the Treatment of Metastatic Ewing Sarcoma

Who this might be right for
Ewing's Sarcoma (ES)
Italian Sarcoma Group 155
Testing effectiveness (Phase 2)Study completedNCT00276692
What this trial is testing

Irinotecan in Treating Patients With Newly Diagnosed Ewing's Sarcoma

Who this might be right for
Sarcoma
Children's Cancer and Leukaemia Group 35
Early research (Phase 1)Study completedNCT00638898
What this trial is testing

Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor

Who this might be right for
Solid TumorAdult Central Nervous System Germ Cell TumorAdult Rhabdomyosarcoma+27 more
City of Hope Medical Center 25
Large-scale testing (Phase 3)Study completedNCT01371981
What this trial is testing

Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaLeukemia CutisMyeloid Neoplasm+1 more
National Cancer Institute (NCI) 1,645
Not applicableUnknownNCT03358628
What this trial is testing

Patient-derived Xenograft (PDX) Modeling to Test Drug Response for High-grade Osteosarcoma

Who this might be right for
Osteosarcoma
Peking University People's Hospital 20
Next Page